Skip to main content

Pharmacological Approaches to Studying Platelet Function

An Overview

  • Protocol
Platelets and Megakaryocytes

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 273))

  • 1100 Accesses

Abstract

Although pharmacology may be strictly viewed as the study of drugs (see, for example, the British Pharmacological Society Web site at http://www.bps.ac.uk/BPS.html), for many of us it also involves the use of drugs to study receptors. Indeed, the fundamental principle behind a pharmacological approach to the study of any biological system is that quantitative analysis of the effects of drugs on the responses of cells, tissues,or whole animals can provide useful information on the receptors involved. The approach is well-suited to situations where it is relatively easy to measure a response that is closely related to receptor activation, and although originally developed using isolated smooth-muscle preparations, platelets are also a very suitable system. Indeed, platelets have some advantages over smooth-muscle preparations in this respect, as the problem of diffusion of drugs through solid tissues is largely avoided in a suspension of cells. In addition, because in general each measurement is made on a separate sample of cells, there is no risk of desensitization due to repetitive addition of drugs to a single tissue, although obviously there may be time-dependent changes in the responses, which have to be taken into account. An important consideration is which response to measure: for platelets, one has the choice of overall functional responses such as shape change, aggregation, and the release of granule contents, which are more complex but may be of pathophysiological relevance, or of simpler biochemical responses such as changes in the levels of intracellular cyclic AMP or calcium. In theory any quantifiable response can be analyzed, although in some cases the results may differ depending on the response measured.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Clark, A. J. (1937) General pharmacology, in Heffter’s Handbuch der Experimentallen Pharmakologie (Clark, A. J., ed.), Vol. 4, Springer-Verlag, Berlin, pp. 1–223.

    Google Scholar 

  2. Leff, P. (1995) The 2-state model of receptor activation. Trends Pharmacol. Sci. 16, 89–97.

    Article  PubMed  CAS  Google Scholar 

  3. Bond, R. A., Leff, P., Johnson, T. D., Milano, C. A., Rockman, H. A., McMinn, T. R., et al. (1995) Physiological effects of inverse agonists in transgenic mice with myocardial over-expression of the beta(2)-adrenoceptor. Nature 374, 272–276.

    Article  PubMed  CAS  Google Scholar 

  4. Stephenson, R. P. (1956) A modification of receptor theory. Br. J. Pharmacol. 11, 379–393.

    CAS  Google Scholar 

  5. Furchgott, R. F. (1966) The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes, in Advances in Drug Research (Harper, N. J. and Simmonds, A. B.,eds.), Vol. 3, Academic Press, New York, pp. 21–55.

    Google Scholar 

  6. Black, J. W. and Leff, P. (1983) Operational models of pharmacological agonism. Proc. R. Soc. Lond. 220, 141–162.

    Article  PubMed  CAS  Google Scholar 

  7. Park, H. S. and Hourani, S. M. O. (1999) Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5′-diphospbate (ADP) in human platelets. Br. J. Pharmacol. 127, 1359–1366.

    Article  PubMed  CAS  Google Scholar 

  8. Hall, D. A. and Hourani, S. M. O. (1993) Effects of analogs of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets. Br. J. Pharmacol. 108, 728–733.

    PubMed  CAS  Google Scholar 

  9. Hourani, S. M. O. (2001) Discovery and recognition of purine receptor subtypes on platelets. Drug Devel. Res. 52, 140–149.

    Article  CAS  Google Scholar 

  10. Palmer, R. K., Boyer, J. L., Schachter, J. B., Nicholas, R. A. and Harden, T. K. (1998) Agonist action of adenosine triphosphates at the human P2Y(1) receptor. Mol. Pharmacol. 54, 1118–1123.

    PubMed  CAS  Google Scholar 

  11. Zhang, F. L., Luo, L., Gustafson, E., Lachowicz, J., Smith, M., Qiao, X. D., et al. (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J. Biol. Chem. 276, 8608–8615.

    Article  PubMed  CAS  Google Scholar 

  12. Uneyama, C., Uneyama, H., and Akaike, N. (1993) Cytoplasmic Ca2+ oscillation in rat megakaryocytes evoked by a novel type of purinoceptor. J. Physiol. 470, 731–749.

    PubMed  CAS  Google Scholar 

  13. Somasundaram, B. and Mahaut-Smith, M. P. (1994) Three cation influx currents activated by purinergic receptor stimulation in rat megakaryocytes. J. Physiol. 480, 225–231.

    PubMed  CAS  Google Scholar 

  14. Mahaut-Smith, M. P., Ennion, S. J., Rolf, M. G., and Evans, R. J. (2000) ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br. J. Pharmacol. 131, 108–114.

    Article  PubMed  CAS  Google Scholar 

  15. Gaddum, J. H. (1937) The quantitative effects of antagonistic drugs. J. Physiol. 89, 7P–9P

    Google Scholar 

  16. Arunlakshana, O. and Schild, H. O. (1959) Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14, 48–58.

    CAS  Google Scholar 

  17. Kenakin, T. P. (1982) The Schild regression in the process of receptor classification. Can. J. Physiol. Pharmacol. 60, 249–265.

    PubMed  CAS  Google Scholar 

  18. Hall, D. A. and Hourani, S. M. O. (1994) Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5′-diphosphate in human platelets. Biochem. Pharmacol. 47, 1013–1018.

    Article  PubMed  CAS  Google Scholar 

  19. Hourani, S. M. O., Hall, D. A., and Nieman, C. J. (1992) Effects of the P2-purinoceptor antagonist, suramin, on human platelet-aggregation induced by adenosine 5′-diphosphate. Br. J. Pharmacol. 105, 453–457.

    PubMed  CAS  Google Scholar 

  20. Cusack, N. J. and Hourani, S. M. O. (1982) Adenosine 5′-diphosphate antagonists and human platelets — no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br. J. Pharmacol. 76, 221–227.

    PubMed  CAS  Google Scholar 

  21. Gaddum, J. H. (1945) Lognormal distributions. Nature 156, 463–466.

    Article  Google Scholar 

  22. Leff, P., Prentice, D. J., Giles, H., Martin, G. R., and Wood, J. (1990) Estimation of agonist affinity and efficacy by direct, operational model-fitting. J. Pharm. Methods 23, 225–237.

    Article  CAS  Google Scholar 

  23. Prentice, D. J. and Hourani, S. M. O. (1997) Information in agonist curve shape for receptor classification, in Ann. N.Y. Acad. Sci., Vol. 812, pp. 234–235.

    Article  Google Scholar 

  24. Cheng, Y. C. and Prusoff, W. H. (1973) Relationship between the inhibition constant (KI) and thc concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.

    Article  PubMed  CAS  Google Scholar 

  25. Lazareno, S. and Birdsall, N. J. M. (1993) Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br. J. Pharmacol. 109, 1110–1119.

    PubMed  CAS  Google Scholar 

  26. Kenakin, T. P. (1997) Pharmacologic Analysis of Drug-Receptor Interaction, 3rd ed., Raven Press, New York.

    Google Scholar 

  27. Kenakin, T. P. and Angus, J. A. (2000) The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems. Handbook of Experimental Pharmacology, 148, Springer-Verlag, Berlin Heidelberg.

    Google Scholar 

  28. Neubio, R.R., Spedding, M., Kenakin, T., and Christopoulos, A. (2003) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII Update on Terms and Symbols in Quantitative Pharmacology. Pharmacol. Rev. 55, 597–606.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Hourani, S.M.O. (2004). Pharmacological Approaches to Studying Platelet Function. In: Gibbins, J.M., Mahaut-Smith, M.P. (eds) Platelets and Megakaryocytes. Methods in Molecular Biology™, vol 273. Humana Press. https://doi.org/10.1385/1-59259-783-1:073

Download citation

  • DOI: https://doi.org/10.1385/1-59259-783-1:073

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-011-3

  • Online ISBN: 978-1-59259-783-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics